Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
Draft ASEAN Equity Disclosure Standards เอกสารรับฟงความคิดเห็น เร่ือง การเปดเผยขอมูลกรณีบริษัทตางประเทศ เขามาเสนอขายหุนในประเทศไทย สํานักงาน สํานักงานคณะกรรมการกํากับหลักทรัพยและตลาดหลกัทรัพย
Equity Coverage Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) 1 of 10 Performance Overview Growth continued both revenue and net profits, attributed to efficient
Equity Coverage Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) 1 of 10 Performance Overview Continuous growth in both revenue and net profits, attributed to
on another overseas exchange simultaneously or in proximate period, on the condition that equity trading volume on such oversea exchange is higher than that on the SET. In addition, the overseas
ที่ กบร No. Kor Bor Ror. 032/2017 November 9, 2017 President The Stock Exchange of Thailand Re : Increase of the investment proportion in the ordinary shares of Pattaya Manufacturing Co., Ltd. Dear
1 No. LorBor. 11/2019 May 13, 2019 Re: Joint Venture in Pulp Mold Manufacturing Project Attn.: President The Stock Exchange of Thailand Kaset Thai International Sugar Corporation Public Company
ที่ กบร No. Kor Bor Ror. 032/2017 November 9, 2017 President The Stock Exchange of Thailand Re : Increase of the investment proportion in the ordinary shares of Pattaya Manufacturing Co., Ltd
SEC Search Search From : Home > Search > Search Results search: Public Information System Debenture Prospectus ( 1,293 ) Equity Prospectus ( 418 ) Investor Alert ( 309 ) Form 246-2 : Reports on
profit (loss) attributable to equity holders 562 402 159 39.6% Net profit (loss) attributable to equity holders Margin (%) 6.9% 5.9% 0.9% Net profit (loss) attributable to equity holders (Exclude Gain